DS-2

N/A

Report date: 2025/01/26 17:21:37

Base Information

Drug NameDS-2
Drug Alias NameDS-2
ClassificationBiologics > Protein drugs > Recombinant polypeptide
Mechanisms of ActionTelomerase inhibitors
TargetsTelomerase
Therapy Area/IndicationsProstatic Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySouth Korea
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesSungkyunkwan University
China Registration ClassN/A

Develop Information

Active CompaniesSungkyunkwan University
Inactive CompaniesN/A
Active IndicationsProstatic Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A